Mealey's (November 29, 2016, 8:28 AM EST) -- BOSTON — The First Circuit U.S. Court of Appeals on Nov. 21 said a district court judge committed no errors in a Nexium generic antitrust case that ended in a defense verdict for defendant AstraZeneca LP (In Re: Nexium [Esomeprazole] Antitrust Litigation, American Sales Company, et al. v. AstraZeneca LP, et al., Nos. 15-2005, 15-2006, 15-2007, 1st Cir.; 2016 U.S. App. LEXIS 20845)....